JP2013136631A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013136631A5 JP2013136631A5 JP2013055494A JP2013055494A JP2013136631A5 JP 2013136631 A5 JP2013136631 A5 JP 2013136631A5 JP 2013055494 A JP2013055494 A JP 2013055494A JP 2013055494 A JP2013055494 A JP 2013055494A JP 2013136631 A5 JP2013136631 A5 JP 2013136631A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- alkyl
- aryl
- compound
- deoxorapamycin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 7
- -1 hydroxyarylalkyl Chemical group 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- QFMKPDZCOKCBAQ-NFCVMBANSA-N sar943-nxa Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)CC1 QFMKPDZCOKCBAQ-NFCVMBANSA-N 0.000 claims 4
- 239000012453 solvate Substances 0.000 claims 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical class CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical class CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000000278 alkyl amino alkyl group Chemical group 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000005094 alkyl carbonyl amino alkyl group Chemical group 0.000 claims 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 2
- 125000004103 aminoalkyl group Chemical group 0.000 claims 2
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 125000004990 dihydroxyalkyl group Chemical group 0.000 claims 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 2
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000005182 hydroxyalkylcarbonyl group Chemical group 0.000 claims 2
- 125000005027 hydroxyaryl group Chemical group 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 claims 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims 1
- 125000006307 alkoxy benzyl group Chemical group 0.000 claims 1
- 125000005197 alkyl carbonyloxy alkyl group Chemical group 0.000 claims 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims 1
- 125000005103 alkyl silyl group Chemical group 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 125000001769 aryl amino group Chemical group 0.000 claims 1
- 125000004657 aryl sulfonyl amino group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000004803 chlorobenzyl group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000005020 hydroxyalkenyl group Chemical group 0.000 claims 1
- 125000005016 hydroxyalkynyl group Chemical group 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 229960002317 succinimide Drugs 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0601406.2 | 2006-01-24 | ||
| GBGB0601406.2A GB0601406D0 (en) | 2006-01-24 | 2006-01-24 | Organic Compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008551707A Division JP5416412B2 (ja) | 2006-01-24 | 2007-01-22 | ラパマイシン誘導体の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013136631A JP2013136631A (ja) | 2013-07-11 |
| JP2013136631A5 true JP2013136631A5 (enExample) | 2013-10-03 |
Family
ID=36060760
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008551707A Expired - Fee Related JP5416412B2 (ja) | 2006-01-24 | 2007-01-22 | ラパマイシン誘導体の製造方法 |
| JP2013055494A Pending JP2013136631A (ja) | 2006-01-24 | 2013-03-18 | ラパマイシン誘導体の製造方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008551707A Expired - Fee Related JP5416412B2 (ja) | 2006-01-24 | 2007-01-22 | ラパマイシン誘導体の製造方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8138344B2 (enExample) |
| EP (1) | EP1979359A1 (enExample) |
| JP (2) | JP5416412B2 (enExample) |
| KR (1) | KR101423343B1 (enExample) |
| CN (2) | CN101374847A (enExample) |
| AU (1) | AU2007209569B2 (enExample) |
| BR (1) | BRPI0707330A2 (enExample) |
| CA (1) | CA2637075A1 (enExample) |
| GB (1) | GB0601406D0 (enExample) |
| RU (1) | RU2448970C2 (enExample) |
| WO (1) | WO2007085400A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0601406D0 (en) * | 2006-01-24 | 2006-03-08 | Novartis Ag | Organic Compounds |
| JP6378192B2 (ja) * | 2012-11-13 | 2018-08-22 | エルジー エレクトロニクス インコーポレイティド | データ送信方法及び装置、並びにデータ送信方法及び装置 |
| WO2014145780A1 (en) | 2013-03-15 | 2014-09-18 | Biosensors International Group, Ltd. | Purification of rapamycin derivatives |
| EP3109250A1 (en) * | 2015-06-23 | 2016-12-28 | Synbias Pharma AG | Method for the synthesis of rapamycin derivatives |
| AR112834A1 (es) | 2017-09-26 | 2019-12-18 | Novartis Ag | Derivados de rapamicina |
| PL3898637T3 (pl) | 2018-12-18 | 2025-05-19 | Novartis Ag | Pochodne rapamycyny |
| CA3127448C (en) | 2019-01-22 | 2024-06-04 | Aeovian Pharmaceuticals, Inc. | Mtorc modulators and uses thereof |
| WO2021195599A1 (en) * | 2020-03-27 | 2021-09-30 | Aeovian Pharmaceuticals, Inc. | Mtorc1 modulators and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5256790A (en) * | 1992-08-13 | 1993-10-26 | American Home Products Corporation | 27-hydroxyrapamycin and derivatives thereof |
| GB9221220D0 (en) * | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
| ATE228135T1 (de) * | 1995-06-09 | 2002-12-15 | Novartis Erfind Verwalt Gmbh | Rapamycinderivate |
| AU2930501A (en) * | 2000-01-07 | 2001-07-24 | Transform Pharmaceuticals, Inc. | High-throughput formation, identification, and analysis of diverse solid-forms |
| GB0601406D0 (en) * | 2006-01-24 | 2006-03-08 | Novartis Ag | Organic Compounds |
-
2006
- 2006-01-24 GB GBGB0601406.2A patent/GB0601406D0/en not_active Ceased
-
2007
- 2007-01-22 WO PCT/EP2007/000514 patent/WO2007085400A1/en not_active Ceased
- 2007-01-22 CN CNA2007800034190A patent/CN101374847A/zh active Pending
- 2007-01-22 AU AU2007209569A patent/AU2007209569B2/en not_active Ceased
- 2007-01-22 JP JP2008551707A patent/JP5416412B2/ja not_active Expired - Fee Related
- 2007-01-22 US US12/160,110 patent/US8138344B2/en not_active Expired - Fee Related
- 2007-01-22 CN CN201410391783.0A patent/CN104211716A/zh active Pending
- 2007-01-22 EP EP07702931A patent/EP1979359A1/en not_active Withdrawn
- 2007-01-22 RU RU2008134424/04A patent/RU2448970C2/ru not_active IP Right Cessation
- 2007-01-22 BR BRPI0707330-5A patent/BRPI0707330A2/pt not_active IP Right Cessation
- 2007-01-22 CA CA002637075A patent/CA2637075A1/en not_active Abandoned
- 2007-01-22 KR KR1020087018088A patent/KR101423343B1/ko not_active Expired - Fee Related
-
2013
- 2013-03-18 JP JP2013055494A patent/JP2013136631A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013136631A5 (enExample) | ||
| JP2019524861A5 (enExample) | ||
| JP2010535722A5 (enExample) | ||
| EP4458348A3 (en) | Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof | |
| SI2906563T1 (en) | Derivatives of pyrrolo (3,2-d) pyrimidine for the treatment of viral infections and other diseases | |
| MY192109A (en) | Aminopyrimidinyl compounds as jak inhibitors | |
| RU2014149149A (ru) | БИЦИКЛИЧЕСКИЕ СУЛЬФОНОВЫЕ СОЕДИНЕНИЯ ДЛЯ ИНГИБИРОВАНИЯ RORгамма АКТИВНОСТИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ | |
| JP2017508789A5 (enExample) | ||
| AR067413A1 (es) | Compuestos heterociclicos que contienen ciclopenta[d]pirimidina inhibidores de proteinquinasas akt, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de las mismas para el tratamiento de enfermedades hiperproliferativas, tales como cancer | |
| JP2013503846A5 (enExample) | ||
| RU2017120970A (ru) | Производные желчной кислоты в качестве агонистов fxr/tgr5 и способы их применения | |
| EP4295841A3 (en) | Sulfur (vi) fluoride compounds and their use in click-reaction | |
| NZ599040A (en) | 2,4-disubstituted pyrido[4,3-d]pyrimidin-5(6h)-one compounds for selective inhibitors of lrrk2 and syk kinases | |
| RU2013151803A (ru) | Бициклические гетероциклические соединения и их применения в терапии | |
| AR082985A1 (es) | INHIBIDORES DE PI3K-d Y METODOS DE SU USO Y PREPARACION | |
| JP2015520140A5 (enExample) | ||
| PH12015501226A1 (en) | Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same | |
| AR085489A1 (es) | Derivados de triazolopiridinas, composiciones farmaceuticas que los contienen, proceso para prepararlos, intermediarios de dicho proceso y uso de los mismos para el tratamiento de enfermedades autoinmunes e inflamatorias | |
| AR080596A1 (es) | Compuestos alquilamido y composiciones farmaceuticas | |
| JP2017527590A5 (enExample) | ||
| RU2013126531A (ru) | Селективные ингибиторы гликозидазы и их применение | |
| MX373022B (es) | Inhibidores de kv1.3 y su aplicacion medica. | |
| RU2008134424A (ru) | Способ получения производных рапамицина | |
| PH12017501655B1 (en) | Morphinan derivative | |
| JP2015500842A5 (enExample) |